Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Hypokalemia from beta2-receptor stimulation by circulating epinephrine.

Brown MJ, Brown DC, Murphy MB.

N Engl J Med. 1983 Dec 8;309(23):1414-9.

PMID:
6314140
2.

Hypokalemia from beta 2-receptor stimulation by circulating epinephrine.

Brown MJ.

Am J Cardiol. 1985 Aug 30;56(6):3D-9D.

PMID:
2863972
3.

Role of epinephrine-induced hypokalemia in the regulation of renin and aldosterone in humans.

Kolloch RE, Kruse HJ, Friedrich R, Ruppert M, Overlack A, Stumpe KO.

J Lab Clin Med. 1996 Jan;127(1):50-6.

PMID:
8592096
4.

Epinephrine-induced hypokalemia: the role of beta adrenoceptors.

Reid JL, Whyte KF, Struthers AD.

Am J Cardiol. 1986 Apr 25;57(12):23F-27F.

PMID:
3010693
5.

Adrenaline causes hypokalaemia in man by beta 2 adrenoceptor stimulation.

Struthers AD, Reid JL.

Clin Endocrinol (Oxf). 1984 Apr;20(4):409-14.

PMID:
6143631
6.

Adrenergic modulation of extrarenal potassium disposal.

Rosa RM, Silva P, Young JB, Landsberg L, Brown RS, Rowe JW, Epstein FH.

N Engl J Med. 1980 Feb 21;302(8):431-4.

PMID:
6101508
7.
8.

Role of nitric oxide in the renin and heart rate responses to beta-adrenergic stimulation.

Reid IA, Bui H, Chou L.

Hypertension. 1994 Jan;23(1 Suppl):I49-53.

PMID:
8282375
9.

Effect of CGP 17/582, a selective beta-adrenoceptor antagonist, on the haemodynamic and hypokalaemic response to adrenaline.

Whyte KF, De Vane PJ, Whitesmith R, Kelman A, Reid JL.

Br J Clin Pharmacol. 1989 May;27(5):553-61.

10.

Catecholamine modulation of magnesium plasma levels in the rat.

Guideri G.

Arch Int Pharmacodyn Ther. 1992 Nov-Dec;320:103-14.

PMID:
1363770
12.

Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure.

Blumberg A, Weidmann P, Shaw S, Gnädinger M.

Am J Med. 1988 Oct;85(4):507-12.

PMID:
3052050
13.

Ritodrine- and terbutaline-induced hypokalemia in preterm labor: mechanisms and consequences.

Braden GL, von Oeyen PT, Germain MJ, Watson DJ, Haag BL.

Kidney Int. 1997 Jun;51(6):1867-75.

14.

Plasma catecholamines and cardiac, renal and peripheral vascular adrenoceptor-mediated responses in different age groups of normal and hypertensive subjects.

Bühler FR, Kiowski W, van Brummelen P, Amann FW, Bertel O, Landmann R, Lütold BE, Bolli P.

Clin Exp Hypertens. 1980;2(3-4):409-26.

PMID:
6253240
15.

Beta 1-adrenoceptor selectivity of single oral doses of bisoprolol and atenolol.

Chang PC, van Veen S, van der Krogt JA, Vermeij P, van Brummelen P.

J Cardiovasc Pharmacol. 1988 Sep;12(3):317-22.

PMID:
2464104
16.
17.

Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.

Leenen FH, Davies RA, Fourney A.

Clin Pharmacol Ther. 1998 Nov;64(5):522-35.

PMID:
9834044
18.

Reduced beta-adrenergic sensitivity in patients with type 1 diabetes and hypoglycemia unawareness.

Korytkowski MT, Mokan M, Veneman TF, Mitrakou A, Cryer PE, Gerich JE.

Diabetes Care. 1998 Nov;21(11):1939-43.

PMID:
9802747
19.

Comparison of the effects of cetamolol and atenolol on epinephrine- and isoproterenol-induced hypokalemia in anesthetized dogs.

Klein M, Stupienski RF, Nettler S, Smith T, Oshiro G.

J Cardiovasc Pharmacol. 1989 Jan;13(1):118-24.

PMID:
2468922
20.

Plasma noradrenaline and adrenaline and beta-adrenoreceptor responsiveness in renin subgroups of essential hypertension.

Bühler FR, Bertel O, Kiowski DW.

Clin Sci Mol Med Suppl. 1978 Dec;4:57s-60s. No abstract available.

PMID:
215376

Supplemental Content

Support Center